Glickman Urological & Kidney Institute Outcomes
Urology - Kidney
Renal Cell Carcinoma
Five-Year Overall Survival of Patients With All Stages of Renal Cell Cancer (N = 4123)
2011-2021
ᵃNational comparison represents survival after diagnosis from Stat Facts: An interactive tool for access to Surveillance, Epidemiology, and End Results (SEER) cancer statistics. Surveillance Research Program, National Cancer Institute. https://seer.cancer.gov/statfacts/html/kidrp.html. Accessed June 27, 2022.
Five-Year Overall Survival of Patients With Renal Cell Cancer by Stageᵃ at Diagnosis (N = 3761)
2011-2021
| Number at Risk | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 |
|---|---|---|---|---|---|
| Stage I (N = 2114) | 1754 | 1464 | 1138 | 873 | 597 |
| Stage II (N = 170) | 144 | 110 | 73 | 57 | 43 |
| Stage III (N = 956) | 742 | 605 | 441 | 320 | 214 |
| Stage IV (N = 521) | 246 | 159 | 97 | 65 | 40 |
ᵃ American Joint Committee on Cancer (AJCC) stage 0-V renal cell carcinoma
